Unilever Q1 2026 Trading Statement: Volume-Led Growth and Foods Combination with McCormick

Unilever Q1 2026 results: strong underlying growth, but currency spoils the headline

Unilever has started 2026 in decent shape. The headline number that matters most here is underlying sales growth (USG) of 3.8%, made up of 2.9% volume growth and 0.9% price growth. In plain English, Unilever sold more stuff, and only a small part of the growth came from charging more.

That is a better-quality result than investors usually get from consumer goods groups in choppy markets. Reported turnover still fell 3.3% to €12.6 billion, but that was mainly because of a nasty (7.7)% currency impact, not because the underlying business went backwards.

Key Q1 2026 figure	Result
Underlying sales growth	3.8%
Underlying volume growth	2.9%
Underlying price growth	0.9%
Turnover	€12.6 billion
Reported turnover change	(3.3)%
Currency impact	(7.7)%
Quarterly dividend	€0.4664 per share / £0.4046 per London-listed share
Share buyback starting now	€1.5 billion

Why Unilever’s 2.9% volume growth is the standout number for investors

For retail investors, the most encouraging part of this update is the mix of growth. Volume growth means more units sold, while price growth means sales rose because prices increased. When volume is doing the heavy lifting, it usually suggests brands are holding up well with shoppers.

That is exactly what Unilever is showing here. Volume growth of 2.9% across the group is strong, and its Power Brands – basically the company’s bigger priority brands – did even better with 5.0% USG and 4.0% volume growth.

That matters because investors have spent the past few years asking whether consumer goods growth is “real” or just inflation being passed on. In Q1, Unilever has given a pretty solid answer. This quarter looks much more like genuine demand than price-led padding.

Unilever business divisions: Home Care leads, Foods still growing before the McCormick deal

All four business groups delivered underlying sales growth, which is another positive. There are no obvious holes in the portfolio from this snapshot, even if some divisions are clearly pulling harder than others.

• Home Care was the star, with 6.1% USG, driven by 6.2% volume growth and (0.1)% price.
• Personal Care delivered 3.7% USG, with 1.1% volume and 2.5% price.
• Beauty & Wellbeing grew 3.6%, split fairly evenly between volume and price.
• Foods grew 2.2%, with 2.4% volume and (0.2)% price.

Home Care is especially worth noticing. A 6.2% volume rise with almost no pricing help suggests Unilever has improved competitiveness in places that matter, especially India and Brazil. That is the sort of progress investors like because it is hard to fake.

Personal Care was more price-led, but still respectable. Dove remains the workhorse brand, and management says Rexona and Axe improved after actions taken in Brazil in the second half of 2025.

Foods is now the interesting strategic subplot rather than the long-term centrepiece. Growth was positive, led by Hellmann’s and improving performance in Unilever Food Solutions, but the division is already mentally half out the door after the announced combination with McCormick.

Emerging markets are doing the heavy lifting while Europe remains the weak spot

Regionally, the split is very clear. Emerging markets grew 5.7%, with a strong 4.2% contribution from volume, while developed markets grew 1.0%. That is perfectly workable for Unilever, but it does show where the energy is coming from.

India was particularly strong with 7% growth and 6% underlying volume growth. Latin America also improved nicely, growing 6.2% and returning to volume growth at 2.6%. That recovery matters because management specifically highlighted corrective actions taken in Brazil last year.

The weak patch is Europe, where underlying sales fell (0.9)%, with volume down (1.2)%. Unilever describes market conditions as soft, and that sounds about right. Good growth in the Netherlands and France was not enough to offset weakness in Germany and Eastern Europe.

My read is simple: emerging markets are keeping the engine humming, while Europe is still trudging uphill. That is not fatal for Unilever, but it does cap the upside if Europe does not stabilise.

McCormick Foods combination: why this could reshape Unilever for years

The biggest strategic announcement is the agreement to combine Unilever’s Foods business with McCormick. Unilever says this will unlock value by turning the group into a pureplay HPC company – meaning more focused on home and personal care – while creating a larger flavours business in Foods.

On paper, the logic is easy to follow. Management says the combined Unilever Foods and McCormick should deliver around $600 million of annual run-rate cost synergies, net of growth reinvestments, plus $100 million of incremental cost and revenue synergies to be reinvested for growth.

There is a sting in the tail, though. Unilever expects €400 million to €500 million of stranded costs after the separation, with those costs to be offset by savings over 2027 to 2029, and it expects €500 million of one-off restructuring costs over that period.

So this is positive, but not free money. If execution goes well, Unilever becomes a simpler, sharper business that could command a better rating. If execution slips, investors may spend the next year hearing more about separation costs than growth benefits.

Dividend, share buyback and productivity savings give investors extra support

Shareholder returns are still very much part of the story. The quarterly interim dividend for Q1 2026 is €0.4664 per share, or £0.4046 per London-listed ordinary share, up 3.0% versus Q1 2025.

On top of that, the €1.5 billion share buyback starts today and is expected to finish on or before 6 July 2026. Unilever also said cash receipts are expected to support a total of €6 billion of share buybacks between 2026 and 2029.

There is also some quiet good news on efficiency. The productivity programme launched in 2024 is ahead of schedule, with €750 million of savings already delivered by the end of Q1 2026, against a target of €800 million by the end of 2026. That should help support margins, especially if commodity costs stay elevated.

Unilever outlook for 2026: guidance unchanged, but the tone is cautiously confident

Management reconfirmed full-year guidance. Unilever still expects 2026 underlying sales growth at the bottom end of its 4% to 6% range, with at least 2% underlying volume growth, and a modest improvement in underlying operating margin versus 20.0% in 2025.

That guidance is not flashy, but it is credible. Q1 came in at 3.8% USG, slightly below the bottom of the annual range, yet volume growth is already running above the full-year floor. That gives management some room, even if currencies, Europe and macro uncertainty remain awkward.

What this Unilever Q1 2026 trading statement really means for retail investors

This was a good update, not a perfect one. The positives are clear: strong volume growth, broad-based category performance, emerging market momentum, savings ahead of target, and extra cash being returned to shareholders.

The negatives are also real: reported sales fell because of currency, Europe remains soft, and the McCormick deal comes with execution risk and meaningful separation costs. But taken together, this feels like a business gaining control of its own story rather than reacting to events.

If you own Unilever shares, the key takeaway is that the underlying engine looks healthier than the reported turnover line suggests. And if management can turn this volume momentum into sustained margin progress while pulling off the Foods separation cleanly, the investment case gets more interesting from here.